CSBR Champions Oncology Corp Yalpi foyda bo'yicha marjinallik

CSBR (championsoncology.com) - kompaniyaning tovar belgisi

Champions Oncology (CSBR) kompaniyasining yalpi foyda marjasi tuzilmasi daromadlilik dinamikasini namoyish etadi, bunda 47.70 qiymati ushbu ko'rsatkichning muvozanatini aks ettiradi. Farma-hamkorlardan mablag'larning barqaror kirib kelishi likvidlik tanqisligini bartaraf etadi. Tirik o'smalarni tahlil qilish bo'yicha uzoq muddatli shartnomalar buyurtmalarning barqarorligini ta'minlaydi. FDA ning yuqori standartlari va noyob PDX modellari saratonni davolash sektoridagi yangi raqobatchilar uchun kirishning sezilarli to'siqlarini yaratadi.

CSBR championsoncology.com Yalpi rentabellik (04.07.2022 - 20.11.2026)

Champions Oncology (CSBR) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- bozor kapitallashuvi bo'yicha ma'lumotlar:
Kompaniyaning jamlanma tahlili:championsoncology.com (CSBR)
Champions Oncology Corp brendining mahsuloti

Champions Oncology (CSBR) kompaniyasining shaxsiylashtirilgan dori-darmonlarni sinovdan o'tkazish bo'yicha yechimlari yetukligi mediana yalpi foyda tendentsiyasida aks etgan bo'lib, u jonli o'simta modellaridan foydalanish samaradorligini ko'rsatadi. Ushbu ko'rsatkich bevosita ishlab chiqarish xarajatlarini chegirib tashlagandan keyin qolgan daromad sifatida hisoblanadi, bu esa investorlarga biznesning foydani kengaytirish qobiliyatini baholash va aktivga haddan tashqari yuqori narx to'lamasdan kirish nuqtasini aniqlash imkonini beradi.

Asosiy raqobatchilar

Yalpi foyda marjasi BeiGene Ltd. (ONC)|Yalpi foyda bo'yicha rentabellik HALO|Yalpi rentabellik RVMD|Yalpi foyda bo'yicha rentabellik AAPG (Ascentage)|Yalpi foyda bo'yicha rentabellik cgoncology.com CGON|UroGen Pharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi BCAX|PSNL - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Erasca Oncology ERAS|delcath.com (DCTH) - Yalpi rentabellik|Y-mAbs Therapeutics - Yalpi foyda normasi|AURA (Aura Biosciences Inc) - Yalpi marja|Yalpi foyda marjasi candeltx.com CADL|Yalpi marja ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Yalpi foyda normasi|Yalpi rentabellik Actuate Therapeutics, Inc. ACTU|citiusonc.com - Yalpi rentabellik|TuHURA Biosciences Inc. - Yalpi marja|TARA - Yalpi marja|FATE (Fate Therapeutics) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Aadi Bioscience, Inc.|Yalpi foyda bo'yicha rentabellik TCRX|Yalpi rentabellik XBIT|Yalpi marja CVM|Yalpi foyda bo'yicha rentabellik OS Therapies Inc. OSTX|Yalpi rentabellik Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Yalpi foyda marjasi|ANL - Yalpi rentabellik|Yalpi foyda marjasi verupharma.com|TPST: Yalpi marja|XLO - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Renovaro|Yalpi marja muraloncology.com|Yalpi marja KAPA|Yalpi foyda bo'yicha sotuv rentabelligi OnKure Therapeutics, Inc.|Yalpi marja GDTC (w2.cytomed.sg)|CRIS - Yalpi foyda bo'yicha rentabellik|Apollomics - Yalpi marja|Tharimmune Corp (THAR) - Yalpi foyda bo'yicha rentabellik|ADVB: Yalpi marja|Yalpi foyda bo'yicha rentabellik Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Yalpi marja|Sotuvning yalpi rentabelligi SBFM (Sunshine Biopharma)|Yalpi rentabellik Xenetic Bio (XBIO)|Yalpi rentabellik SLRX (Salarius Pharma)|Kitov Pharma - Yalpi foyda bo'yicha rentabellik|American Oncology Network (AONC) - Yalpi foyda marjasi|BeiGene - Yalpi marja|Checkpoint Therapeutics, Inc. (CKPT) - Yalpi foyda bo'yicha rentabellik|ELEV (Elevation Oncology, Inc.) - Yalpi foyda bo'yicha rentabellik|iCAD Inc. - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik IKNA|Yalpi marja notablelabs.com|Yalpi foyda bo'yicha rentabellik VIRX (Viracta Therapeutics Inc.)|MOR - Yalpi foyda marjasi|Yalpi rentabellik NAYA Biosciences NAYA|AAPGV - Yalpi foyda bo'yicha rentabellik